Further, we validated in a Panc 02 pancreatic cancer model that the knockdown of ZDHHC3 in tumor cells could delay tumor growth, which was associated with enhanced anti-tumor immune response. This evidence concerns the gene ZDHHC3 and familial pancreatic carcinoma.